Upgrade to SI Premium - Free Trial

Summit Therapeutics plc (SMMT) PT Lowered to $23 at H.C. Wainwright

May 4, 2026 7:28 AM
(Updated - May 4, 2026 7:32 AM EDT)

H.C. Wainwright analyst Mitchell S. Kapoor lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change